GNBT Generex Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GNBT Generex

GNBT 0.00

Jan 27 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MJ who wrote (222)	11/17/2007 12:12:28 PM
From: Hawkmoon	Read Replies (1) of 310

Well.. I think GNBT's CEO has finally recognized that she needs to spend more time promoting her company's stock... I'll admit that I'm not particularly keen on Anna Gluskin. I don't think she has the "face presence" or credibility to take this company to major levels on its own. Bernstein, the former head of the American Diabetes Association, would be a far better "face man" for the company, IMO. But I think that he's been the power behind the scenes in creating that credibility in the medical sector, and that might overcome her lack of leadership style. All in all, I think the stock is definitely worth $5/share as it stands right now (in comparison to other biotech stocks), so I have to agree that it's a screaming buy at the moment. Hawk

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next